Literature DB >> 22623798

Characterization of a viral phosphoprotein binding site on the surface of the respiratory syncytial nucleoprotein.

Marie Galloux1, Bogdan Tarus, Ilfad Blazevic, Jenna Fix, Stéphane Duquerroy, Jean-François Eléouët.   

Abstract

The human respiratory syncytial virus (HRSV) genome is composed of a negative-sense single-stranded RNA that is tightly associated with the nucleoprotein (N). This ribonucleoprotein (RNP) complex is the template for replication and transcription by the viral RNA-dependent RNA polymerase. RNP recognition by the viral polymerase involves a specific interaction between the C-terminal domain of the phosphoprotein (P) (P(CTD)) and N. However, the P binding region on N remains to be identified. In this study, glutathione S-transferase (GST) pulldown assays were used to identify the N-terminal core domain of HRSV N (N(NTD)) as a P binding domain. A biochemical characterization of the P(CTD) and molecular modeling of the N(NTD) allowed us to define four potential candidate pockets on N (pocket I [PI] to PIV) as hydrophobic sites surrounded by positively charged regions, which could constitute sites complementary to the P(CTD) interaction domain. The role of selected amino acids in the recognition of the N-RNA complex by P was first screened for by site-directed mutagenesis using a polymerase activity assay, based on an HRSV minigenome containing a luciferase reporter gene. When changed to Ala, most of the residues of PI were found to be critical for viral RNA synthesis, with the R132A mutant having the strongest effect. These mutations also reduced or abolished in vitro and in vivo P-N interactions, as determined by GST pulldown and immunoprecipitation experiments. The pocket formed by these residues is critical for P binding to the N-RNA complex, is specific for pneumovirus N proteins, and is clearly distinct from the P binding sites identified so far for other nonsegmented negative-strand viruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22623798      PMCID: PMC3421704          DOI: 10.1128/JVI.00058-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Structural analysis of the human respiratory syncytial virus phosphoprotein: characterization of an alpha-helical domain involved in oligomerization.

Authors:  María T Llorente; Blanca García-Barreno; Miguel Calero; Emilio Camafeita; Juan A López; Sonia Longhi; François Ferrón; Paloma F Varela; José A Melero
Journal:  J Gen Virol       Date:  2006-01       Impact factor: 3.891

2.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

3.  Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication.

Authors:  Q Yu; R W Hardy; G W Wertz
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

Review 4.  Structural disorder within paramyxovirus nucleoproteins and phosphoproteins.

Authors:  Johnny Habchi; Sonia Longhi
Journal:  Mol Biosyst       Date:  2011-08-01

5.  Determination of phosphorylated residues from human respiratory syncytial virus P protein that are dynamically dephosphorylated by cellular phosphatases: a possible role for serine 54.

Authors:  Ana Asenjo; Lorena Rodríguez; Nieves Villanueva
Journal:  J Gen Virol       Date:  2005-04       Impact factor: 3.891

Review 6.  Unravelling the complexities of respiratory syncytial virus RNA synthesis.

Authors:  Vanessa M Cowton; David R McGivern; Rachel Fearns
Journal:  J Gen Virol       Date:  2006-07       Impact factor: 3.891

7.  The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner.

Authors:  Thi-Lan Tran; Nathalie Castagné; Virginie Dubosclard; Sylvie Noinville; Emmanuelle Koch; Mohammed Moudjou; Céline Henry; Julie Bernard; Robert Paul Yeo; Jean-François Eléouët
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

8.  Solution structure of the C-terminal nucleoprotein-RNA binding domain of the vesicular stomatitis virus phosphoprotein.

Authors:  Euripedes A Ribeiro; Adrien Favier; Francine C A Gerard; Cédric Leyrat; Bernhard Brutscher; Danielle Blondel; Rob W H Ruigrok; Martin Blackledge; Marc Jamin
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

9.  RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.

Authors:  H Grosfeld; M G Hill; P L Collins
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  34 in total

1.  Biochemical characterization of the respiratory syncytial virus N0-P complex in solution.

Authors:  Camille Esneau; Bertrand Raynal; Pierre Roblin; Sébastien Brûlé; Charles-Adrien Richard; Jenna Fix; Jean-François Eléouët; Marie Galloux
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

2.  New Insights into Structural Disorder in Human Respiratory Syncytial Virus Phosphoprotein and Implications for Binding of Protein Partners.

Authors:  Nelson Pereira; Christophe Cardone; Safa Lassoued; Marie Galloux; Jenna Fix; Nadine Assrir; Ewen Lescop; François Bontems; Jean-François Eléouët; Christina Sizun
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

3.  Identification and characterization of the binding site of the respiratory syncytial virus phosphoprotein to RNA-free nucleoprotein.

Authors:  Marie Galloux; Gaëlle Gabiane; Julien Sourimant; Charles-Adrien Richard; Patrick England; Mohammed Moudjou; Magali Aumont-Nicaise; Jenna Fix; Marie-Anne Rameix-Welti; Jean-François Eléouët
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

4.  Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Authors:  Monika Bajorek; Marie Galloux; Charles-Adrien Richard; Or Szekely; Rina Rosenzweig; Christina Sizun; Jean-Francois Eleouet
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

5.  Inhibition of Respiratory Syncytial Virus Replication by Simultaneous Targeting of mRNA and Genomic RNA Using Dual-Targeting siRNAs.

Authors:  Somayeh Shatizadeh Malekshahi; Vahid Salimi; Ehsan Arefian; Ghazal Fatemi-Nasab; Sarvin Adjaminejad-Fard; Jila Yavarian; Talat Mokhtari-Azad
Journal:  Mol Biotechnol       Date:  2016-11       Impact factor: 2.695

6.  Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Authors:  Peter L Collins; Rachel Fearns; Barney S Graham
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

7.  Functional correlations of respiratory syncytial virus proteins to intrinsic disorder.

Authors:  Jillian N Whelan; Krishna D Reddy; Vladimir N Uversky; Michael N Teng
Journal:  Mol Biosyst       Date:  2016-04-26

8.  Structural studies on the authentic mumps virus nucleocapsid showing uncoiling by the phosphoprotein.

Authors:  Robert Cox; Adrian Pickar; Shihong Qiu; Jun Tsao; Cynthia Rodenburg; Terje Dokland; Andrew Elson; Biao He; Ming Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

9.  A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus.

Authors:  Mohamed Ouizougun-Oubari; Nelson Pereira; Bogdan Tarus; Marie Galloux; Safa Lassoued; Jenna Fix; M Alejandra Tortorici; Sylviane Hoos; Bruno Baron; Patrick England; Didier Desmaële; Patrick Couvreur; François Bontems; Félix A Rey; Jean-François Eléouët; Christina Sizun; Anny Slama-Schwok; Stéphane Duquerroy
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

10.  Structure-guided design of small-molecule therapeutics against RSV disease.

Authors:  Robert Cox; Richard K Plemper
Journal:  Expert Opin Drug Discov       Date:  2016-04-21       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.